Trends in Endometriosis Management: A 10-Year US Claims Analysis
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This US claims analysis examined endometriosis management trends over a decade, detailing changes in diagnostic and therapeutic approaches employed by healthcare providers.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
STUDY OBJECTIVE: To examine real-world treatment patterns for endometriosis and their alignment with clinical best-practice recommendations.
DESIGN: Observational, retrospective study from 2009 to 2022.
SETTING: Two large US health insurance claims databases, MarketScan® and OPTUM®.
PATIENTS: Women aged 16-45 years with continuous enrollment in OPTUM® and MarketScan® and at least 2 diagnoses of endometriosis. Hysterectomy, menopause or active treatment of malignancy were exclusion criteria.
INTERVENTIONS: Pharmacological therapy (including OCPs, POPs, GnRH analogs, opioids), and surgical management (including laparoscopy and hysterectomy).
MEASUREMENTS: Frequencies, means, Time-to-event Kaplan-Meier curves, and Sankey diagrams were used to examine treatment initiation, frequencies and sequences.
MAIN RESULTS: A total of 22 317 participants from OPTUM® and 54 630 from MarketScan® were included. Most of these patients (71.0% OPTUM®, 72.1% MarketScan®) received surgery after diagnosis of endometriosis, whereas medications were prescribed in 42.1% (OPTUM®) and 44.9% (MarketScan®). Surgery was performed as a first-line intervention in 37.6% (n = 8395, including 4481 laparoscopies and 3914 hysterectomies in OPTUM®) and 41.8% (n = 22 858, including 13 175 laparoscopies and 9683 hysterectomies in MarketScan®). Among first-line surgeries (n = 8395 OPTUM®, n = 22 858 MarketScan®), laparoscopies accounted for over half (53.4%, n = 4481 OPTUM®; 57.6%, n = 13 175 MarketScan®), while hysterectomies comprised nearly half (46.6%, n = 3914 OPTUM®; 42.4%, n = 9683 MarketScan®). Pharmacotherapy was used first-line in 49.9% (n = 11 135) of OPTUM® and 45.5% (n = 24 840) of MarketScan®. Opioids were used first-line in 12.5% (n = 2787) OPTUM® and 12.7% (n = 6932) MarketScan®. Pharmacological therapies were started as first-line intervention within 15-23 weeks, and surgeries were performed within 16-18 weeks after diagnosis. Those with gynecologic comorbidities had a shorter diagnosis-to-treatment interval than those with mental health and pain comorbidities.
CONCLUSION: Therapies for endometriosis are generally started within 4-6 months of diagnosis. Surgery is used more frequently than medical management, and in the majority of cases, surgery was first-line intervention. Opioids are still frequently prescribed despite strong guidelines recommending against their use.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (11)
- Clinical Diagnosis and Early Medical Management for Endometriosis: Consensus from Asian Expert Group via openalex
- Clinical diagnosis of endometriosis: a call to action via openalex
- Consensus on current management of endometriosis via openalex
- Diagnosis and management of endometriosis via openalex
- Economic burden of endometriosis via openalex
- Endometriosis and infertility: a committee opinion via openalex
- Presence of endometriosis and chronic overlapping pain conditions negatively impacts the pain experience in women with chronic pelvic-abdominal pain: A cross-sectional survey via openalex
- W4280645308 via openalex
- W4214754424 via openalex
- W2989014249 via openalex
- W4390578581 via openalex
Cited by (3)
- Endometriosis-associated Pain: Mechanism, Neuroimmune Signature, and Translational Precision Strategies 2026
- Why Are We Still Talking About Endometriosis? A Call for Structural Change in Complex Benign Gynecologic Care 2026
- Regarding "Equity and Data Gaps in Real-World Endometriosis Management" 2025
Source provenance
- europepmc
- last seen: 2026-10-08T06:18:23.926119+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T06:12:09.149390+00:00
- unpaywall
- last seen: 2026-08-14T06:25:32.811723+00:00
License: CC0
· commercial use OK